Rchr
J-GLOBAL ID:200901063821914833   Update date: Oct. 31, 2024

Yoshida Tatsushi

ヨシダ タツシ | Yoshida Tatsushi
Affiliation and department:
Job title: Assistant Professor
Research field  (3): Tumor biology ,  Food sciences ,  Molecular biology
Research keywords  (5): 細胞死 ,  転写調節 ,  機能性食品 ,  がん ,  分子標的薬
Research theme for competitive and other funds  (23):
  • 2022 - 2025 Establishment of new intervention methods for hematopoietic transcriptional control for clinical application.
  • 2022 - 2023 高食塩摂取が免疫系に及ぼす影響の解析
  • 2021 - 2022 コーヒー成分によるがん免疫調節機能の解明
  • 2020 - 2022 キノコ成分による免疫調節機構の解明
  • 2019 - 2021 造血転写制御への新規介入方法の探索とその臨床応用に向けた研究
Show all
Papers (61):
  • Renshi Kawakatsu, Kenjiro Tadagaki, Kenta Yamasaki, Yasumichi Kuwahara, Shinichiro Nakada, Tatsushi Yoshida. The combination of venetoclax and quercetin exerts a cytotoxic effect on acute myeloid leukemia. Scientific Reports. 2024. in press
  • Kozue Nose, Keiko Taniguchi, Mitsugu Fujita, Chiami Moyama, Masaya Mori, Mizuki Ishita, Tatsushi Yoshida, Hiromi Ii, Toshiyuki Sakai, Susumu Nakata. γ-Glutamylcyclotransferase is transcriptionally regulated by c-Jun and controls proliferation of glioblastoma stem cells through Notch1 levels. Cancer Gene Ther. 2024. in press
  • Tatsushi Yoshida, Kenta Yamasaki, Mano Horinaka, Kenjiro Tadagaki. Coffee extracts and caffeine upregulate the expression of the immune checkpoint factors, PD-1 and PD-L1. INTERNATIONAL JOURNAL OF FUNCTIONAL NUTRITION. 2024. 5. 2
  • Renshi Kawakatsu, Kenjiro Tadagaki, Kenta Yamasaki, Tatsushi Yoshida. Venetoclax efficacy on acute myeloid leukemia is enhanced by the combination with butyrate. Scientific Reports. 2024. 14. 1
  • Tatsushi Yoshida, KentaYamasaki, KenjiroTadagaki. Caspase inhibition improves viability and efficiency of liposomal transfection. Scientific Reports. 2023. 13. 1. 21868
more...
MISC (53):
more...
Books (14):
  • [がん治療における分子標的:その課題と未来展望] 細胞死シグナルの最新理解とがんの分子標的薬
    京都府立医科大学雑誌 2023
  • 細胞死のすべて TRAIL創薬
    医学のあゆみ 2022
  • 【がん研究・診療を巡る最新トピックス】細胞死とがん
    京都府立医科大学雑誌 2019
  • Encyclopedia of Cancer 4th ed.
    Springer 2016
  • 【腫瘍の生化学と分子生物学:最新の理解】造血の転写制御と白血病
    京都府立医科大学雑誌 2015
more...
Education (3):
  • 1996 - 1999 千葉大学大学院 自然科学研究科 情報システム科学専攻
  • 1994 - 1996 千葉大学大学院修士課程理学研究科生物学専攻
  • 1990 - 1994 Chiba University Graduate School, Division of National Science and Technology
Professional career (1):
  • 博士(理学)
Work history (7):
  • 2014 - 現在 Kyoto Prefectural University of Medicine
  • 2013 - 2014 Tokyo Medical and Dental University Medical Research Institute
  • 2011 - 2013 Tokyo Medical and Dental University Medical Research Institute
  • 2009 - 2011 Tokyo Medical and Dental University Medical Research Institute
  • 2007 - 2009 米国Food and Drug Administration (FDA) 研究員
Show all
Awards (3):
  • 2020/02 - 京都府立医科大学 DDP GP表彰
  • 2008/10 - 日本衛生学会 奨励賞
  • 2005/03 - 京都府立医科大学 青蓮賞
Association Membership(s) (6):
分子生物学会 ,  THE JAPANESE ASSOCIATION FOR MOLECULAR TARGET THERAPY OF CANCER ,  THE JAPANESE SOCIETY OF HEMATOLOGY ,  THE JAPANESE SOCIETY FOR HYGIENE ,  THE JAPANESE CANCER ASSOCIATION ,  THE JAPANESE BIOCHEMICAL SOCIETY
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page